The widely used chemotherapeutic cisplatin causes ototoxicity as late-term side effect. In this issue, Benkafadar et al (2017) decipher the mechanism of cisplatin-induced ototoxicity and provide evidence that transient inhibition of p53 ameliorates ototoxicity without influencing chemotherapeutic efficacy. These findings may open exciting perspectives for reducing (late-term) side effects of cancer treatment.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2hSNXGt
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου